| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
144,920,000 |
| Market
Cap: |
31.68(B) |
| Last
Volume: |
450,553 |
Avg
Vol: |
720,140 |
| 52
Week Range: |
$134.65 - $225.46 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 516 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
39,684 |
42,684 |
82,362 |
295,126 |
| Total Sell Value |
$8,143,214 |
$8,601,074 |
$15,799,208 |
$63,449,607 |
| Total People Sold |
6 |
6 |
9 |
11 |
| Total Sell Transactions |
7 |
8 |
24 |
74 |
| End Date |
2024-02-20 |
2023-11-19 |
2023-05-21 |
2022-05-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Douglas Robert Andrew |
President and COO ResMed Inc. |
• • – |
2020-11-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
478 |
215,358 |
|
- |
|
| Douglas Robert Andrew |
President and COO ResMed Inc. |
• • – |
2020-11-24 |
4 |
AS |
$211.00 |
$201,505 |
I/I |
(955) |
215,836 |
|
-5% |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2020-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
135,181 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2020-11-20 |
4 |
OE |
$84.98 |
$99,936 |
D/D |
1,176 |
145,181 |
|
- |
|
| Burt Carol |
Director |
• • – |
2020-11-19 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,187 |
1,187 |
|
- |
|
| Drexler Karen |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
594 |
6,981 |
|
- |
|
| Burt Carol |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
2,914 |
|
- |
|
| De Witte Jan |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
4,320 |
|
- |
|
| Farrell Peter C |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
228,636 |
|
- |
|
| Gill Harjit |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
5,345 |
|
- |
|
| Sulpizio Richard |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
12,867 |
|
- |
|
| Taylor Ronald R |
Director |
• • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,187 |
22,769 |
|
- |
|
| Sandercock Brett |
Chief Financial Officer |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$5,636,066 |
D/D |
26,246 |
110,600 |
|
- |
|
| Leong Justin |
President, Asia Latin America |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$2,536,724 |
D/D |
11,813 |
37,199 |
|
- |
|
| Sodhi Rajwant |
President, SaaS Business |
• • – |
2020-11-17 |
4 |
D |
$214.74 |
$2,200,870 |
D/D |
(10,249) |
35,675 |
|
- |
|
| Sodhi Rajwant |
President, SaaS Business |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$3,945,418 |
D/D |
18,373 |
45,924 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2020-11-17 |
4 |
D |
$214.74 |
$10,688,898 |
D/D |
(49,776) |
399,146 |
|
- |
|
| Farrell Michael J. |
Chief Executive Officer |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$19,162,968 |
D/D |
89,238 |
448,922 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2020-11-17 |
4 |
D |
$214.74 |
$2,672,439 |
D/D |
(12,445) |
144,005 |
|
- |
|
| Pendarvis David |
Chief Administrative Officer |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$4,790,849 |
D/D |
22,310 |
156,450 |
|
- |
|
| Douglas Robert Andrew |
President and COO ResMed Inc. |
• • – |
2020-11-17 |
4 |
D |
$214.74 |
$7,506,881 |
D/D |
(34,958) |
47,080 |
|
- |
|
| Douglas Robert Andrew |
President and COO ResMed Inc. |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$12,681,900 |
D/D |
59,057 |
82,038 |
|
- |
|
| Hollingshead James |
President, Sleep Business |
• • – |
2020-11-17 |
4 |
D |
$214.74 |
$3,338,563 |
D/D |
(15,547) |
93,133 |
|
- |
|
| Hollingshead James |
President, Sleep Business |
• • – |
2020-11-17 |
4 |
A |
$214.74 |
$5,636,066 |
D/D |
26,246 |
108,680 |
|
- |
|
| Hollingshead James |
President, Sleep Business |
• • – |
2020-11-11 |
4 |
D |
$212.11 |
$1,108,275 |
D/D |
(5,225) |
82,434 |
|
- |
|
1262 Records found
|
|
Page 14 of 51 |
|
|
1.40 (0.64%) 
